Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

What is the Knowledge and Use of Emergency Contraception

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03688581
Recruitment Status : Unknown
Verified September 2018 by University Hospital, Strasbourg, France.
Recruitment status was:  Recruiting
First Posted : September 28, 2018
Last Update Posted : April 18, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The main objective is to assess the knowledge of women seeking abortion about emergency contraception.

The secondary objectives are to evaluate the use of emergency contraception among women seeking abortion and to identify barriers to the efficacy and use of emergency contraception in these women.


Condition or disease
Abortion

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 250 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: What is the Knowledge and Use of Emergency Contraception for Women Who Are Seeking Abortion in University Hospitals of Strasbourg
Actual Study Start Date : July 1, 2018
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : July 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Birth Control

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Assessment of women's knowledge of contraceptive methods through a questionnaire [ Time Frame: 1 hour after consultation for abortion ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Sampling Method:   Non-Probability Sample
Study Population
woman seeking an abortion at the Orthogeny Center in University Hospitals of Strasbourg
Criteria

Inclusion Criteria:

  • women aged over eighteen years old
  • the patient agreed that her questionnaire data should be collected and analyzed for this research.
  • women who are able to read and write French
  • woman seeking an abortion at the Orthogeny Center in University Hospitals of Strasbourg

Exclusion Criteria:

  • refusal to participate in the study
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03688581


Contacts
Layout table for location contacts
Contact: Karima BETTAHAR, MD 33 3 69 55 34 53 karima.bettahar@chru-strasbourg.fr
Contact: Eva TILLY 33 3 69 55 34 53 evatly67@gmail.com

Locations
Layout table for location information
France
Service de Gynécologie - CMCO Recruiting
Strasbourg, France, 67303
Contact: Karima BETTAHAR, MD    33 3 69 55 34 53    karima.bettahar@chru-strasbourg.fr   
Contact: Eva TILLY    33 3 69 55 34 53    evatly67@gmail.com   
Principal Investigator: Karima BETTAHAR, MD         
Sub-Investigator: Catherine BURGY, Wise woman         
Sub-Investigator: Eva TILLY         
Sponsors and Collaborators
University Hospital, Strasbourg, France
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03688581    
Other Study ID Numbers: 7116
First Posted: September 28, 2018    Key Record Dates
Last Update Posted: April 18, 2019
Last Verified: September 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
Abortion
Emergency contraception
Emergency pill
Perception of pregnancy risk
Contraceptive failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Disease Attributes
Pathologic Processes